Insulin treatment of adipocytes increased the amount or activity of a low molecular weight, acid-stable material which, when isolated from intact adipocytes by heat extraction and subsequent Sephadex G25 chromatography, yielded a single active fraction that stimulated mitochondrial pyruvate dehydrogenase by activating the phosphatase and not by altering the kinase activity. Phosphatase activation was demonstrated by the ability of the active material to increase pyruvate dehydrogenase activity in the absence of ATP and by the ability of NaF, a phosphatase inhibitor, to block this stimulation. Involvement of the kinase in this activation mechanism was eliminated by the fact that, in the presence of ATP, (1) NaF completely blocked the stimulation of pyruvate dehydrogenase by the active fraction, and (2) the stimulation of pyruvate dehydrogenase by dichloroacetic acid, a kinase inhibitor, was additive to the stimulation caused by the active fraction. This active fraction may contain an intracellular chemical mediator or second messenger for insulin. DIABETES 29:852-855, October 1980.
T he mechanism by which the binding of insulin to its receptor on the plasma membrane results in alterations of various metabolic pathways remains unknown. 1 Recent studies have provided some insight into the molecular events that occur after the interaction of insulin with its plasma membrane receptor. The direct addition of insulin to a subcellular system consisting of plasma membranes and mitochondria from rat adipocytes resulted in a decreased phosphorylation of the alpha subunit of mitochondrial pyruvate dehydrogenase 2 - with concomitant stimulation of pyruvate dehydrogenase activity in the mitochondria. 4 This latter effect also was produced by the direct addition of concanavalin A or anti-insulin receptor antibody, 4 both of which mimic insulin action. These effects were observed only when the plasma membranes were present, suggesting that a chemical mediator of insulin action was being generated by the interaction of insulin with the plasma membrane. Lamer et al. 7 reported that insulin increased the amount or activity of a low molecular weight material extracted from rabbit skeletal muscle, inhibiting glycogen synthase kinase and stimulating glycogen synthase phosphatase. This material simulated the activation by insulin of pyruvate dehydrogenase activity in isolated mitochondria from rat adipocytes. 8 The present study demonstrates that insulin increased the amount or activity of a similar low molecular weight, acid-stable material which, when isolated from intact adipocytes, stimulated pyruvate dehydrogenase activity in adipocyte mitochondria, apparently by activation of the calcium-sensitive phosphatase. This mechanism is analogous to the one suggested for insulin activation of the enzyme in the intact cell 9 and insulin stimulation of pyruvate dehydrogenase in the plasma membrane-mitochondrial mixture from adipocytes. 10 This material from adipocytes and muscle may represent a chemical mediator or second messenger generated by the insulin-receptor interaction.
MATERIALS AND METHODS
Adipocytes were prepared from the epididymal fat pads of 12 120-g Sprague-Dawley rats by collagenase digestion as previously described.
11 * 12 Equal aliquots of adipocytes were incubated in Krebs-Ringer phosphate buffer, pH 7.4, in the presence or absence of 100 fil) of insulin/ml for 10 min at 37°C. The adipocytes were centrifuged for 1 min and the incubation medium was removed. The insulin-treated and control cells were then heated without buffer for 3 min at 100°C followed by the addition of 3 vol of 0.2 M acetate buffer, pH 3.8, containing 0.1 mM EDTA and 0.1 mM cysteine and then reheated at 100°C for 4 min. The mixture was cooled on ice and filtered through glass wool to remove fat and denatured protein. The absorbance at 260 nm was measured for each set of cells and was found to be within 5% of each other. The colorless supernatant was treated with acid-washed Norit to remove nucleotides and then lyophilized. The white powder was dissolved in 1.0 ml of 0.05 M formic acid and chromatographed on Sephadex G25 (column, 3 x 26 cm). Three-milliliter fractions were collected in the first 9 tubes and 1-ml fractions were collected in the remaining tubes. The eluate was in 0.05 M formic acid. All fractions were collected at a flow rate of 10 drops/min and their absorbance at 230 and 260 nm was determined. Insulin, the /3-chain of insulin, and uridylyl (3'-»5') adenylyl (3'-»5') adenosine (UAA; MW 936.7) were used to calibrate the column, as indicated in Figure 1 . Fractions were collected as indicated, diluted to a final volume of 60 ml with 0.05 M formic acid, lyophilized, and redissolved in 1.5 ml of 0.001 M formic acid. For control material, 60 ml of 0.05 M formic acid was lyophilized and redissolved in 1.5 ml of 0.001 M formic acid. Each fraction was tested for its ability to alter pyruvate dehydrogenase activity in mitochondria isolated from adipocytes as previously described. 8 A mixture of 50 fi\ of each fraction and 150 fi\ containing 250-500 fig mitochondrial protein, 50 fiM Mg 2+ , 50/iM Ca 2+ , and 125 fiM disodium ATP in 50 mM potassium phosphate buffer, pH 7.4, was incubated at 37°C for 5 min. The assay was initiated by the addition of 0.25 mM 1-14 C pyruvate (1 mCi/mmol), 0.5 mM NAD, 1 mM coenzyme A, 0.1 mM co-carboxylase, and 1.0 mM dithiothreitol in 50 mM potassium phosphate buffer, pH 7.4. After 2 min, the assay was stopped by the addition of 200 /xl of 6 M H 2 SO 4 . The enzyme activity was determined as the amount of 14 CO 2 produced. 4 
RESULTS AND DISCUSSION
Measurement of the absorbance of the control cell extract at 230 or 260 nm revealed a single peak at molecular weight 1,000-1,500, as determined by the location of the molecular weight markers (Figure 1 ). The extract from insulin-treated cells had an identical pattern on Sephadex G25 chromatography, with equivalent peak heights. The eluate was divided as indicated in Figure 1 , lyophilized, and redissolved in 0.001 M formic acid. Each fraction was tested for its ability to stimulate pyruvate dehydrogenase activity in adipocyte mitochondria ( Figure 2 ). Only fraction III, the first half of the 230 nm peak, contained material capable of stimulating pyruvate dehydrogenase. In the presence of ATP, fraction III from insulin-treated cells increased pyruvate dehydrogenase activity by 6.7 nmol/mg/min more than the same fraction from the control cells. In the absence of ATP, the same fraction from insulin-treated cells stimulated pyruvate dehydrogenase activity by 5.1 nmol/mg/min more than control fraction III, indicating that ATP was not required for the active fraction to stimulate pyruvate dehydrogenase (data not shown). This extraction experiment has been repeated seven times, and in all cases the activity from insulin-treated cells was significantly greater than that from control cells, never being less than a 75% increase and, usually, two-to fourfold. No correlation could be made in any experiment between the quantity of active material and the absorbance at 230 or 260 nm, indicating the impurity of the fractions tested.
Pyruvate dehydrogenase is a multienzyme complex whose activity is regulated by the degree of phosphorylation of the alpha subunit of pyruvate decarboxylase. 13 The phosphorylation of the alpha subunit occurs through the action of a kinase and phosphatase contained within the multienzyme complex. Enzyme activity may be increased by activation of the phosphatase and/or inhibition of the kinase. The ability of the active fractions to stimulate pyruvate dehydrogenase activity in the absence of ATP indicates that a phosphatase was activated, since the kinase would be inactive without its substrate, ATP.
Dichloroacetic acid, a kinase inhibitor, and NaF, a phosphatase inhibitor, were used to further distinguish the role of these two regulatory enzymes. 13 ' 14 The data in Table 1 demonstrate the ability of the Sephadex G25-active fractions from control and insulin-treated cells to stimulate pyruvate dehydrogenase in the absence or presence of ATP and the ability of NaF to block this activation. As mentioned above, in a separate experiment, these active fractions stimulated pyruvate dehydrogenase activity by approximately the same absolute magnitude with or without ATP. The data in Table 1 show an even greater stimulation in the absence of ATP than in the presence of ATP. The variability between this experiment and that shown in Figure 2 results from using different mitochondrial preparations. The chemical mediator in the active fraction from insulin-treated cells markedly stimulated the pyruvate dehydrogenase compared with the material from control cells in the absence or presence of ATP. This greater insulin effect occurred in all seven extraction experiments. In the presence of ATP, the control-active fraction only increased enzyme activity by + 0.3 nmol/mg/min. This low level of stimulation is attributable to the inability of the active fraction to activate the phosphatase sufficiently to overcome the rate of kinase-induced phosphorylation. The ability of NaF to block the activation of the pyruvate dehydrogenase by the active fractions in the absence of ATP confirmed the concept of phosphatase activation. Experiments performed in the presence of ATP showed that NaF still completely suppressed the simulation of pyruvate dehydrogenase by the active fraction from both control and insulin-treated cells, suggesting that only the phosphatase was altered by the active fractions. If the stimulation of pyruvate dehydrogenase activity involved both inhibition of kinase and activation of phosphatase, NaF would not have caused a complete suppression of pyruvate dehydrogenase activity in the presence of ATP.
The use of dichloroacetic acid demonstrated that inhibition of the kinase was not involved in the activation of pyruvate dehydrogenase by the insulin-sensitive factor. A concentration of dichloroacetic acid was used that provided maximal stimulation of pyruvate dehydrogenase in the presence of ATP (data not shown) and was assumed to have caused maximal inhibition of the kinase. Figure 3 illustrates that, in the presence of ATP, the active fraction III from insulin-treated cells and dichloroacetic acid individually stimulated pyruvate dehydrogenase activity and, when together, had additive effects. If the chemical mediator in fraction III acted by inhibiting the kinase as well as by stimulating the phosphatase, then an additive effect with dichloroacetic acid should not have been seen.
These studies document that insulin treatment of adipocytes increases the amount or activity of a low molecular weight, acid-stable material which, when isolated from the cells, stimulates the mitochondrial pyruvate dehydrogenase by activating the phosphatase and not by altering kinase activity. The involvement of the phosphatase was demonstrated by the ability of the active material to increase pyruvate dehydrogenase activity in the absence of ATP and by the ability of NaF, a phosphatase inhibitor, to block this stimulation. The involvement of the kinase in the mechanism for activating pyruvate dehydrogenase was eliminated by the data showing that, in the presence of ATP, (1) NaF completely blocked the stimulation of pyruvate dehydrogenase by the active fraction, and (2) the stimulation of pyruvate de- 
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hydrogenase by dichloroacetic acid, a kinase inhibitor, was additive to the stimulation caused by the active fraction. This insulin-sensitive material extracted from adipocytes that stimulates pyruvate dehydrogenase activity in isolated mitochondria resembles material isolated and partially purified from adipocyte plasma membranes (F. L. Kiechle et al., unpublished observations). This latter material (1) is insulinsensitive, that is, insulin increases the amount of its activity; (2) has a similar molecular weight, as determined by gel chromatography; and (3) stimulates pyruvate dehydrogenase by activating the phosphatase and not by inhibiting the kinase. It has not yet been proved that the low molecular weight insulin-sensitive materials isolated from rat adipocytes, adipocyte plasma membranes, and rabbit skeletal muscle 7 are identical, but they have several properties in common. Since they all can modulate metabolism in a manner similar to that of insulin, and since insulin can increase production of the material from all three sources, it is suggestive that they represent an intracellular chemical mediator or second messenger for insulin.
